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1. Introduction  
The aim of this chapter is to give an overview of the applications of magnetic and 
magnetoelastic sensors and actuators in Biomedicine. 
Over the last century, life expectancy on our planet has experienced a remarkable increase. 
That is if we exclude those regions ravaged by war and those others in which the population 
lives, or more probably survives, under conditions that we would not tolerate. In Europe 
this increase has been spectacular. Average life expectancy has reached 80 years old among 
the male population and even more for the female population and the tendency is upward. 
However, this has caused important health problems, as our bodies are not usually 
prepared to function for such a long time without repairs and/or replacements. 
As a result, so-called substitution surgery is now taking up an increasing percentage of the 
operations performed in hospitals; such as bone prostheses for hips, knees and teeth, 
implants for eyes and ears and artificial sphincters and penises. Besides this, it is necessary 
to make periodic analyses in order to test that the levels of glucose, and cholesterol, etc. are 
correct. So, the application of magnetism in Biomedicine covers a wide field of devices, from 
sensors to determine the concentration of several elements in the blood to prostheses, both 
active and passive, for replacing organs or articulations. 
Apart from all the above, some experimental treatments also use magnetic sensors or 
actuators. For example, magnetic nanoparticles are used for hyperthermia treatments 
against tumour cells or for drug delivery. In addition, much more sophisticated and 
expensive treatments, like magneto encephalography techniques, use magnetic elements. 
In this chapter we are going to describe a small number of devices, some of which are now 
being researched. They are divided in two categories: magnetic sensors and magnetic 
actuators, according to the following scheme: 
 Magnetic Sensors 
 In situ measurement of the mass evolution of cell culture 
 Test of blood coagulation 
 Sensor system for early detection of heart valve bio prostheses failure 
 Magnetic Actuators 
 Magnetic endoluminal artificial urinary sphincter 
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 Hyperthermia HeLa cell treatment with silica-coated manganese oxide 
nanoparticles 
In the development of these magnetic devices, as well as others not described here, there are 
some aspects that are common to the magnetic devices used in other very different fields as, 
for example, railway sensors, automotive sensors or aerospace vehicles. These may apply 
the basic magnetic properties or the signal acquisition and control process. Nevertheless, 
there are some aspects, as for instance,  biocompatibility, corrosion resistance, size limitation 
and patient comfort, in the case of a human implant, that are specific to this application. We 
will try to describe them through our work in this area. 
2. Magnetic sensors 
Magnetic sensors are based, with very few exceptions, on the same working principle: the 
change of magnetic moment that takes place in a magnetic material, (normally 
ferromagnetic), when submitted to a magnetic field, a change of temperature or, in the case 
of magnetoelastic materials, to a mechanical stress, generated by the medium, in which they 
are immersed. The measurement of this variation makes it possible to study the changes that 
occur in the surroundings of the sensor.  
In the case of the biomedical applications, the medium may be a fluid like, for instance, blood, 
the cerebrospinal fluid or a culture medium or it may be organic tissue. In any case there will 
be an interaction between both elements, the magnetic material and the organic medium, 
which is undesirable. On the one hand, the organic media may be harmed since the most 
widely used magnetic materials, (transition metals and their alloys), are not biocompatible, 
except for iron which is very biocompatible; (human organs and tissues have a great affinity 
for iron). On the other hand, the above mentioned organic fluids have Cl-, Ca=, Na+, K+ ions 
and several free organic radicals which are, in general, corrosive for  magnetic materials. The 
solution to this problem consists in coating the magnetic material with a thin layer (100 to  
200 nm) of another biocompatible material, like gold, platinum, titanium oxide, silica or 
alumina.  The most widely used coating methods are evaporation, sputtering, electrolysis and 
ionic implantation. The non metallic parts of the sensor also have to be made of biocompatible 
polymers or ceramics such as Teflon, medical silicones, and silica. 
Another aspect that has to be taken into account regarding these sensors is the transmission 
and monitoring of the signal. Wireless transmission, which is one option in other application 
fields, is a compulsory one in biosensors. This is for obvious reasons in the case of internal 
implants, while in the case of the external ones wireless transmission is convenient so as not 
to restrict the patient’s movement. Magnetic sensors and actuators offer a great advantage 
from the start: the magnetic field is itself a wireless transmission. The advances that have 
taken place in the past decades in the field of cellular phones, combined with magnetic 
sensors and biosensors, open the door to the final development of “telediagnosis”.  
The sensors that are presented in this section are based on the magnetoelastic properties of 
several magnetostrictive ferromagnetic alloys (Chikazumi, 1964). As is well known, a 
magnetostrictive material is characterized by a change of its macroscopic dimensions when 
its magnetization changes, getting longer or shorter (positive or negative magnetostriction 
respectively) along the direction of the magnetization. In other words, the energy of the 
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magnetizing field is used not only in the magnetization process but also in elastically 
deforming the material. The opposite phenomenon also takes place. When the material is 
deformed due to an external stress, not all the mechanical work is used in deforming the 
material, a part of the stress is used in magnetizing the material. In the free energy of the 
solid, a third term has to be added to the terms of elastic and magnetic energy that is called 
the magnetoelastic energy term. It takes into account the energy transfer between the elastic 
system and the magnetic one: 
 
F  Fel () Fmg(m) Fmgel (m,)  (1) 
As a consequence, in these materials the magnetic susceptibility changes with the 
deformation (and consequently with stress) of the material and, inversely, the elastic 
constant of the material changes with its magnetization (and thus the applied magnetic 
field). The magnetic coupling term, being the one that takes into account the energy 
exchange between both systems, shows a resonance phenomenon: it has a maximum for a 
particular frequency that depends on the magnetic and elastic properties of the material.  
The materials that are most widely used are the amorphous magnetostrictive alloys, in 
which the absence of magnetocristalline anisotropy makes it easy to control the resonance 
frequency, acting on the magnetic anisotropy of the material by means of appropriate 
thermal treatments. The amorphous magnetic materials with positive magnetostriction 
constant, made by the Taylor technique (Marín & Hernando, 2004), are well known due to 
their availability for use in wireless sensors based on magnetoelastic resonance (Vázquez & 
Hernando, 1996). Some recent works show the possibility of using these materials as 
magnetoelastic biosensors(Shem et al., 2009; Xie et al., 2009). Other works show a detailed 
study of the magnetoelastic coupling phenomenon in ribbons (Hernando 1983). Recently, 
there has been published a development, for monitoring in situ the mass of a cell culture, 
based on the magnetoelastic resonance of ribbon shaped metallic glasses (Rivero et al., 2008). 
On the other hand, magnetic amorphous microwires coated with Pyrex have attracted much 
interest due to their particular properties and their simple manufacturing process based on 
the Taylor technique. The use of these materials can reduce the dimensions of the set-up and 
the Pyrex cover makes them appropriate for many applications in the medical field. 
2.1 In situ measurement of the mass evolution of cell culture 
Cell cultures constitute one of the most frequently used assays in biology and also one of the 
diagnostic methods most used in Medicine. The growing of several microorganism strains, 
like cells, bacteria and virus etc., under conditions in which atmosphere, temperature, 
humidity and nutrients are controlled have been studied. 
On the other hand, the research on the treatment of tumours by hyperthermia, in the last 
decade, has been focused on the different behaviour of normal and tumour cells over 
temperature. Generally, normal cells show better temperature resistance than the tumour 
ones. Consequently, it is very important to determine the optimum temperature for   
hyperthermia treatments. 
The monitoring of the progress of a cell culture is conventionally done by direct observation 
of the evolution that takes place on a culture plate, (the support on which the cells are 
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placed), using a microscope. It is essential to have perfect control over the 
microenvironment in which the culture is developing to ensure that any change in the 
behaviour and multiplication of the cells is only ascribable to the cell behaviour in a given 
situation and not to poor culture conditions. For this reason, the cultures are carried out 
inside incubation chambers where it is possible to control factors such as humidity, pH and 
temperature. Among all these factors, probably the most important one is strict control of 
the temperature since it is a critical factor in the majority of the experiments performed with 
cells, particularly in mammalian ones. However when the evolution of the cells is observed 
using a microscope, it is necessary to extract the cells from the chamber, submitting them 
with what may result in undetermined damages due to changes in temperature, aside from 
the mechanical damages that take place in each measurement. 
So a system that makes it possible to continuously quantify the mass evolution of a cellular 
culture “in situ”, that is, without extraction from the incubation chamber would be very 
useful and to our knowledge, it does not exist. This sensor would enable the cellular growth 
to be studied accurately under different temperatures, without the periodical mechanical 
damage and the cooling-heating processes produced by the extraction and movement of the 
culture from the chamber to the microscope where the counting of the cells is performed. 
One solution is a system sensor based on the magneto-elastic resonance of ferromagnetic 
amorphous ribbons. Other systems based on the same principle have been developed before 
for detecting other biological agents (Lakshmanan et al., 2007; Wan et al., 2007) 
The system consists of the following elements (Fig.1): 
 A culture plate that has been designed with two separate baths, each one containing an 
amorphous magnetoelastic ribbon with an iron based composition of area 40 x 4 mm2 
and 15 microns in thickness, coated with 250 nm of TiO2 immersed in a culture 
medium. Only one bath is seeded with cells. So we have a continuous reference 
independent of temperature. 
 An arrangement of two coils and a permanent magnet under the plate to apply the bias 
and the alternating field. 
 A scanner impedance meter (Fig. 2), connected to the coils, which measures the coils 
impedance around the resonance frequency of the ribbons. 
 A software program developed to extract the ribbons resonance frequency from the 
impedance measurements. 
The working of the device is as follows. Inside the culture plate designed for the device two 
ribbons of an amorphous magnetostrictive material with the same dimensions are placed in 
the compartments designed for them immersed in the culture environment. One of the 
ribbons acts as a reference, in order to evaluate the changes on the magnetoelastic resonance 
frequency due to possible changes of temperature or other factors that are not directly 
related to the evolution of the cell culture. So, it is immersed in one of the baths containing 
the culture environment but without cells. A seed of the cells, whose evolution and growth 
is being studied, is placed in the bath containing the other ribbon. By means of the coils 
system (excitation-pick up system) an electromagnetic field of frequency  is applied over 
the whole set-up and the variations in the magnetic flux density, created by the sensor 
system, are collected. The designed electronic system makes it possible to change the 
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frequency of the applied electromagnetic field as well as receiving the answer of the sensor 
in function of the frequency. 
 
Fig. 1. Experimental set-up to measure the mass evolution of cell culture. 
To perform the measurement an electronic system is used. Its flowchart is shown in figure 2. 
By means of a DDS (1) (Direct Digital Synthesizer) device the values of two sinusoidal 
signals in quadrature, sin(t) and cos(t) are obtained. By means of (2) a fixed voltage 
difference is generated that is used by the D/A (Analogical/Digital) (3) and A/D (8) 
converters. The sinusoidal signal sin(t) generated by (1) is transformed into an analogical 
signal by the D/A converter. This signal is amplified by means of a power amplifier (4). The 
amplified signal feeds the excitation/pick up system (5) that is made up by two opposite 
series connected coils, which generate an alternating magnetic field that energizes the 
magnetostrictive ribbons (6) and that also enables answer from the magnetoelastic sensor  
to be picked up. 
The variations in the induced voltage created in the pick up system are converted into 
electric current variations by the voltage/current converter (7). By means of the 
analogical/digital converter we can obtained the digital measurement of the electric 
current that flows through the exciting coils. The digital signal processor (9) permits us to 
extract the in phase and in quadrature components of the current measured by (8) and by 
(10) we obtain, for each frequency, the magnitude of the impedance of the coil system, 
which makes it possible to measure the resonance frequency of the coils / magnetoelastic 
sensor setup. 
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1) Direct Digital Synthesizer; 2) Voltage reference; 3) D/A Converter; 4) Power amplifier; 5) 
Exciting/Pick up coils; 6) Magnetoelastic sensor; 7) Voltage/Current Converter; 8) A/D converter; 9) 
Digital signal processor; 10) Acquisition 
Fig. 2. Flowchart of the scanning impedance meter: 
When the frequency of the electromagnetic field matches the frequency of the 
magnetoelastic resonance of any of the ribbons, the transformation of magnetic energy into 
an elastic one reaches a maximum. This resonance is detected by the coil system, showing a 
characteristic peak in the measurement of the coil impedance. The change of the magnetic 
resonance frequency when the mass of a magnetostrictive material changes by m is given 
by (Grimes et al, 1999): 
 
2
    m
m
 (2) 
Where  is the initial resonance frequency, m is is the initial mass, m is the change of mass 
and   is the resonance frequency variation. Thus, the resonance frequency of a 
magnetoelastic ribbon decreases when the mass on the ribbon increases. Before the cells are 
seeded, both ribbons have the same resonance frequency and only one resonance peak is 
detected. When the culture cells on the seeded ribbon grow, two different peaks appear, 
corresponding to both ribbons, as shown in figure 3. The frequency interval between the 
peaks determines the amount of culture mass. 
Preliminary experiments have been made with a human cervical cancer cell line (HeLa) in 
Dulbecco’s modified Eagle medium, supplemented with 10% fetal bovine serum (FBS) and 
1% (v/v) antibiotic solution. Changes in the mass culture of less than 1% have  
been detected.  
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Fig. 3. Evolution of the resonance of ribbons arrangement. In the initial state A, both ribbons 
have the same resonance frequency. The left peak increases and decreases its frequency with 
the amount of mass on the corresponding ribbon. 
2.2 Test of blood coagulation 
The Time of Prothrombine (TP), and the values that derive from it, like the International 
Normalized Ratio (INR), are used for determining the tendency of the blood to coagulate in 
the presence of possible biological disorders like hepatic failure or K vitamin deficiency. It is 
also used to control patients that take anticoagulation drugs like warfarina or acenocumarol  
to prevent coronary thrombosis processes in cardiac pathologies: atrial fibrillation, and 
auricular fibrillation, etc. In addition, due to the increase in life expectancy, an ever growing 
percentage of the population needs to replace one or more cardiac valves with a mechanical 
prosthesis and, in some cases, more than once. All these people must be submitted to a life-
long treatment using anticoagulants. This entails a permanent risk for them. So it is not rare 
that the problem of controlling the appropriate level of the anticoagulation agent in the 
treatment of several pathologies may affect about 1 – 2 % of people in the European 
Community. The Food and Drugs Administration (FDA) of USA estimates that about two 
million people begin a treatment with warfarin every year. These patients need to be 
controlled periodically due to the side effects of the treatment. These controls must be done 
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in hospital. Nowadays, there are some portable devices (Neel et al., 1998; Askew et al., 2010) 
that enable the control to be done more conveniently, but the results are not very reliable. 
The main causes of error are usually the influence of temperature and the amount of blood 
involved in the test. Other methods based on the measurement of blood viscosity 
(Drobrovol’skii et al., 1999) need a large amount of blood. 
A sensor, based on a magnetoelastic material, can be used to determine the TP and the INR 
in patients under anticoagulation treatment, without the need for specialized staff or 
installations. The method is based on the variation in the magnetic permeability of a 
magnetoelastic microwire induced by the change on the blood viscosity when it coagulates. 
When the blood coagulates, the viscosity force applied to the immersed wire dissipates, as 
heat, a portion of the magnetic energy supplied by the magnetic field. Therefore the 
apparent magnetic permeability of the microwire decreases due to the magnetoelastic 
coupling. The experimental set-up compares this permeability with that of a reference wire 
immersed in an inalterable fluid. The absolute value of the measured signal tends to a 
maximum when the blood coagulates. The time to raise this maximum enables the TP and 
the INR to be calculated.  
The sensor consists of two identical microwires, with an iron base, that are placed into 
two capillaries with tenths of mm. inner diameter and around 5 cm in length. These 
capillaries are surrounded by one coil each, which are fed by two power amplifiers driven 
by a signal generator. The capillaries are filled with blood and with a fluid of reference, 
respectively. The difference between both signals increases when the blood coagulation 
process begins and its absolute value tends to a maximum when the blood is fully clotted. 
The scheme of the experimental set-up used to measure the blood coagulation is 
illustrated in figure 4. 
 
 
Fig. 4. Scheme of the experimental setup used to measure the blood coagulation. 
The sensor system consists of the following components (see figure): 
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 A signal generator that provides a sinusoidal voltage signal in a range of 10 – 50 KHz. 
(1) 
 Two power amplifiers, driven by the signal of the generator, which feed two equal coils 
with the microwire arrangements.  The gain of amplifiers can be adjusted to obtain zero 
signal before the test.  (2) 
 Coil with reference arrangement (capillary + microwire + fluid of reference) (3) 
 Coil with measurement arrangement (capillary + microwire + blood) (4) 
 Two precision rectifiers (5) 
 Two non-inductive resistors (6) 
 A differential amplifier that gives the difference between the rectified voltages in the 
non-inductive resistors. (7) 
 A temperature controlled chamber in which the sensor system is introduced to perform 
the test at constant temperature of 25 ºC.  
 A temperature sensor (8) that measures the temperature in the temperature controlled 
chamber. The signal of the temperature sensor is sent to a temperature controller device 
(9) that keeps the chamber temperature at 25 ºC. 
Tests with blood samples that coagulate at different rates are illustrated in figure 5. 
 
Fig. 5. Study of the influence in the coagulation of blood with different amounts of coagulant 
agent. The amount of blood is 200 l, and was mixed with 5l of coagulant (curve A), 1l of 
coagulant (curve B), and without coagulant (curve C).  
It can be observed that blood, in the presence of the greatest quantity of coagulant agent, 
coagulates in a time 10 times faster than the blood without the coagulant agent. The output 
potential, VOUT,
 
of the differential amplifier shown in figure 4 is the difference between VREF 
(Voltage difference in the circuit of the reference coils) and VBLOOD (Voltage difference in the 
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circuit we are measuring the blood in). Both are RL circuits and the inductance L and 
resistance RL:    
 
L  0 N
2
l
SC  W SW                RL  2N  SCCu SCu  (3) 
Being W   the relative permeability of the microwire, μ0   the permeability of free space, N the 
number of turns, l the length of the coil, Cu the copper conductivity and SC and SW the 
sections of the coil and the microwire, respectively. 
Since in this setup, when R0 and RL << w L then: 
 
VS V0 eit  V  V0 R0L e
i t 2 
 
(4) 
Once they are rectified, the voltage differences are: 
 
VREF  V0 R0 2 LREF and VBLOOD  V0
R0 2
 LBLOOD  
(5) 
Where LREF and LBLOOD are the inductances of the reference and measurement coils, 
respectively. Thus the output of the differential amplifier (see figure 1): 
 










This output is taken to zero at the initial moment, adjusting the gain of the feeding 
amplifiers. From this moment, the permeability, W, of the microwire immersed in blood 
begins to decrease because of the effect of the viscosity force the blood exerts on it while it 
clots. This makes LBLOOD decrease as well. 
The output of the differential amplifier depends on time as follows: 
 










 LBLOOD (0) 1
SC  SW W (0)






Figure 6 shows the curve obtained from human blood without coagulant agent and the 
theoretical VOUT(t) curve, following the equation (7). In this expression the best adjustment 
to experimental results is obtained assuming a relative permeability change of the microwire 
during the coagulation process as: 
   2, ,0 , 2( ) exp            W W W W
t
t  (8) 
Being W,0 and W, the measured values of the initial permeability and the permeability 
when the blood is completely coagulated, respectively, and  a time constant that depends 
on the coagulation properties of the blood sample. The value of  for the best adjustment to 
the experimental values enables the TP and INR to be determined. 
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Fig. 6. The points with a green circle represent the experimental data of the coagulation of 
blood without coagulant. The line in red represents the proposed approximation adjusted to 
the experiment.  
2.3 Sensor system for early detection of heart valve bioprostheses failure 
Heart valves are widely used in cardiac diseases. For example in 2002 in Spain 9269 heart 
valves were implanted as against 310 heart transplants. There are two kinds of heart valves, 
mechanical and biological ones. Biological heart valves, currently made with calf 
pericardium, have a similar shape to that of the original ones and better hemodynamic 
conditions than the mechanical ones. Moreover they have the advantage that the patient 
does not need lifelong treatment with anticoagulants, as happens with the mechanical 
valves. On the other hand, biological cardiac valves, or bioprostheses, have the 
inconvenience of their limited durability (about 10 years on average). What is more 
troublesome is the fact that they have an important dispersion that may be estimated in 
plus/minus 3 years (Kouchoukos et al, 2003). 
These bioprostheses fail for several reasons, similar to those of the original ones and there 
are many factors that may contribute to their deterioration. The most important are 
biochemical degradation and mechanical damage of the tissue. Mechanical fatigue is the 
result of the great number of opening and closing cycles (approximately 30 million per 
year), which the valve is submitted to. Their effects are cumulative, and are expressed by 
lineal ruptures and/or perforations. 
This means that it is difficult to determine the best moment for replacing the valve. The 
problem of the user getting it done too late must be balanced against the economic costs to 
the Social Security system, if is carried out unnecessarily early. So, a sensor is needed that 
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can continuously monitor the working of the valve and give physicians objective data in 
order for them to make the substitution of the valve at the right time. This sensor has to be 
non-invasive and biocompatible. If small samples of soft magnetic material are inserted in 
the valve their movement can be detected when the valve is submitted to an alternating field 
of a frequency ranging from a few tens of Hz to tens of MHz, depending on the magnetic 
material used and its morphology (fig 7). 
The material inside the body cannot interfere with the normal working of the valve. Each 
element’s mass should not be higher than a few micrograms and its section must be of  
10-8 m2 or lower. Different soft magnetic materials meet these requirements as for example 
amorphous ribbons and wires made by melt spinning or amorphous microwires made by 
rapid quenching.  
 
Fig. 7. Detection of motion of bioprostheses cusps with microwires inserted. 
The best results are obtained by using an amorphous Co-based microwire as a magnetic 
element. This microwire has a diameter of 20 m and is coated in the manufacturing process 
itself by a glass layer. The total diameter of the coated microwire is 45 m.  It presents 
remarkable advantages over other materials (Marin P. & Hernando A. 2004): 
 It can be integrated in the cusps without the usage of biological glues. 
 Due to its minimum size it neither diminishes the cusps flexibility, nor does it change 
their mass in an appreciable way. 
 It is coated, during the process of manufacture, by a biocompatible glass, so facilitating 
its integration. 
 Despite its reduced size the magnetic signal obtained is comparable to that obtained 
with the other models. 
 Its high-shape anisotropy (10mm×45m) together with its high-magnetic susceptibility 
makes it possibly to greatly reduce the energy expense needed for the sensor working. 
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The sensor works as follows. An excitation field is generated by an external coil. This field 
magnetizes the soft materials attached to the cusps and this magnetization triggers to a signal, 
the carrier signal, having the same frequency as that of the excitation one (2 kHz). The working 
of the valve causes a movement of the magnetic elements together with the cusps, producing a 
change in their position with respect to the exciting and detection coils (fig 7). This change in 
the relative position causes a modulation in the carrier signal (2 kHz) that clearly has the 
frequency of the opening and closing of the valve (cardiac rhythm, 60–80 cycles/min).  
The dysfunctions produced in the movement of the cusps during the opening and closing of 
the valve, due to degradation, hardening or rupture processes, provoke a change in the 
modulated signal, which is monitored against the signal obtained in the standard working 
conditions. The comparison between both signals may allow the medical services to 
establish precisely the moment when the valve must be replaced (Rivero at al., 2007). All 
this may be done by wireless, without any need to implant, in the patient, any electrical or 
electronic device for detection or transmission, or to establish any type of material joint with 
the valve to the patient. 
This sensor has been tested in a hydrodynamic setup. Figure 8 shows the signal that is 
received in the pickup coils.  Three different series of images corresponding to the opening 
process of the valve with different damage levels can be seen. The electrical signal obtained 
by the sensor system is superimposed on the corresponding image. The first row (a) 
corresponds to the opening process of the undamaged valve. The second row (b) 
corresponds to the valve with a slightly glued commissure, and the third row (c) 
corresponds to the same valve but with the three commissures slightly glued. In the last case 
it can be seen that there is a dramatic change in the electrical signal, as well as in the 
movement of the cusps. 
 
Fig. 8. Opening process of the valve with different damage levels. 
3. Magnetic actuators 
The working of most conventional electromagnetic actuators is based on the force exerted by 
a magnetic field on a moving element, made of a ferromagnetic element, that eventually can 
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become a permanent magnet. The magnetic field that acts on the material can be created by 
a coil, with the appropriate feeding (with alternate or direct current) or by a permanent 
magnet. This force is used to change the moving element.    
Other kind of magnetic actuators are based on the change in dimensions or the deformation 
that takes place in a magnetostrictive magnetic material (see section 2) when there exists a 
variation of the magnetic field that is acting on it. As in the previous case this field can be 
originated by a coil or a permanent magnet when it changes its position or its orientation. 
This kind of actuators, based on the effect commentated in section 2 of this chapter, present 
great advantages for their application on biomedicine since their magnetic field is not 
shielded by human body tissues due to their low conductivity. In other words the actuator 
field can be established by devices placed outside the human body although the actuator 
element is an internal implant. The limits imposed by the size and biocompatibility 
requirements are the same as the ones described in section 2 for the magnetic sensors. 
There are other kinds of recent applications of magnetic actuators related to temperature. A 
general property of magnetic materials, except the ferrites, is an electrical conductivity in the 
range of metal and metal alloys, ranging between 104 and 107 S/m. This means that if the 
actuator field is an alternating one with a frequency , eddy currents will be induced in the 
element that will dissipate a Joule power proportional to the conductivity value, the square 
of the magnetic field amplitude and the square of the frequency. 
 
2 2
0 JouleW B  (9) 
Moreover, any ferromagnetic material will dissipate, through heat, the power needed for the 
magnetization process, which will be proportional to the frequency. 
 Hyst
hystloop
W HdB   (10) 
If the frequency is high, (between 10 KHz and 103 KHz), the power dissipated through both 
causes may mean a significant local increase in the medium temperature. This behavior has 
been used by numerous researchers in the past decade in order to try to find a treatment 
against tumors (hyperthermia) which would be not too aggressive for the patient. In order to 
avoid the danger of creating an embolism in narrow capillaries, nanoparticles with diameters 
ranging from five to a few hundreds of nanometers are used. To avoid the particles 
aggregating because of the attraction of their magnetic moment, superparamagnetic materials 
or ferromagnetic materials functionalized with polar radicals that cause electrostatic repulsion 
are used. Another application of these particles, (in their hollow mode), is to use them as a 
vehicle for transporting medicines to the place in the organism where they have to act. Once 
they are there they are heated with a high frequency magnetic field that provokes their 
fragmentation and frees the medicine inside the nanoparticle. 
These magnetic actuators have given rise to a new kind of materials, using traditional 
materials as a starting point but reducing them to smaller and smaller sizes. One only has to 
consider that in a gold cube with a 1 micron side just one part in a million of their atoms are 
arranged on the surface while in a cube of 2 nm 60 % of them are on the surface. So it is not 
strange that their physical properties become very different from that of bulk gold when 
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reaching the limit where gold nanoparticles of diameter 1.5 nm demonstrate a spontaneous 
magnetic moment (Crespo et al., 2004). 
3.1 Magnetic endoluminal artificial urinary sphincter 
Urinary incontinence is not considered an illness but a symptom and is only treated when it 
becomes a social problem. Urinary incontinence is defined by the complaint of any 
involuntary leakage of urine (Abrams et al., 2002)  or unintentional loss of urine that occurs 
with such frequency and in such quantities as to cause physical and/or emotional distress in 
the person experiencing it. Moreover, the number of people suffering from this is  
estimated to be around a million people among the adult population in western countries 
(Irwin et al., 2006). 
Depending on the origin and the severity of the affection, it is treated with absorbent pads, 
pharmacological or surgical methods. For more than 30 years physicians have implanted 
inflatable artificial sphincters that simulate the sphincter function and permit the voluntary 
control of the micturition (American Medical System). However this device requires highly 
invasive surgery since it is necessary to implant a cuff around the urethra, in addition to a 
balloon, that regulates the cuff pressure and a bulb that controls the inflation and deflation 
of the cuff. 
The objective of developing a magnetic artificial urinary sphincter is to look for a minimally 
invasive device that permits voluntary micturition control, making use of the potential of 
the magnetic field to exert a force without physical contact. 
The preliminary specifications for the device are the following: 
 Voluntary opening by the patient 
 Automatic closing 
 Automatic opening when the safety pressure is reached 
 External magnetic drive, without other devices 
 Urethral implantation without surgery 
 Immunity to RF fields 
The device consists of a magnetic valve placed in the urethra. The urine is evacuated by 
bringing a permanent magnet near the body of the patient. The magnetic valve consists on 
(Figure 9) a hollow cylindrical body valve with a toroidal magnet fixed at one of their ends 
and a soft magnetic material piston that is attracted by the magnet, closing the evacuation 
hole. As a sealing gasket a medical grade silicone O-ring is used. 
If a more powerful external magnet is brought near the valve, the magnetization of the 
piston (made of a soft magnetic material) is reversed and a repulsion force between the 
internal magnet and the piston appears, causing the evacuation hole to open. When the 
external magnet is moved away, the interaction between the internal magnet and the piston 
turns attractive again and the valve closes automatically. Furthermore, the system is 
provided with a safety system preventing overpressure in the bladder. By adjusting  
the distance between the piston and the internal magnet, a pressure level can be fixed  
in such a way that if the pressure inside the bladder reaches that value, then the valve  
opens automatically. 
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Fig. 9. Sketch of the magnetic valve. 
Figure 10 shows the sphincter prototype for the trials performed on animal models, in the 
Service of Experimental Surgery of Puerta de Hierro Hospital. 
 
 
Fig. 10. Sphincter prototype for trials on animal models. 
Fig 11 shows the operating system of the valve and its relative position concerning the 
bladder. Without any external action, the valve is in its closed position thanks to the action 
of the magnetic force exerted by the internal magnet (Fig11, A).  
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Fig. 11. Sketch of the magnetic valve operation. A) Closed position. B) Open position. 
From the point of view of the biocompatibility of the system the ferromagnetic elements are 
the most critical ones. For the piston, a Fe based alloy is used, PM2000, that previous studies 
have proved, has a good biocompatibility (Flores et al., 2004) together with a good 
magnetization for the fields that the magnet produces at millimetres distances. Moreover, the 
NdFeB magnet has been coated with gold in order to isolate it from the biological medium. For 
the body valve, a medical grade polyurethane with biomedical grade has been chosen. The 
problem regarding the fixation to the urethra has been solved by adapting the valve to a 
urinary ball-probe. Trials on experimental animals have shown good preliminary results. 
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3.2 Hyperthermia HeLa cell treatment with silica-coated manganese  
oxide nanoparticles 
The treatment of tumours by hyperthermia is based on the killing of tumour cells by heating 
them. Temperatures over around 42ºC kill tumour cells. Moreover, the behaviour of normal 
and tumour cells is different with temperature; generally, normal cells show better 
resistance to temperature than the tumour ones (Hahn et al., 1974). If it is possible to heat 
the tumour area at temperatures that would kill tumour cells but not the normal cells, we 
would be able to treat tumours selectively with less damage to the body than other therapies 
such as chemotherapy.  
As mentioned above, in the past years nanoparticles have attracted much attention for 
medical applications due to their small size that enables them to be inserted inside the body 
and transported round it. In particular, magnetic nanoparticles have been used as a heating 
source for magnetic hyperthermia. Under the influence of an alternating high-frequency 
magnetic field, they generate heat through hysteresis losses, induced eddy currents and 
Neel and/or Brown relaxation processes (Jordan et al., 1993). Thus, different kinds of 
magnetic nanoparticles have been tested as a heating source. The new materials must satisfy 
stringent conditions: they must be biocompatible, be stable in aqueous solution, possess 
high thermal efficiency as heating elements and be highly accumulating inside tumour cells, 
so that when applying the alternating magnetic field (AMF) the increase in temperature can 
induce cellular death (Kong et al., 2001). Superparamagnetic iron oxide is the most common 
material tested up to now due to its high biocompatibility, low synthesis cost, enhanced 
specific loss power and easy functionalization (Hergt et al., 1998). However, in spite of these 
advantages, it is not possible to control the local heating temperature, because it is not 
possible to measure the exact temperature or distribution of temperature in a tissue under 
magnetic particle hyperthermia (MPH) treatment. Therefore, the temperature reached in a 
tissue under MPH treatment will depend on a large number of particle parameters, such as 
size and concentration in the tissue of the nanoparticles, the conditions of the external 
applied field, and the length of the treatment (Gazeau et al., 2008). 
To avoid the obstacle of temperature control, new materials of tunable Curie temperature 
(Tc) are being intensively investigated to achieve temperature autostabilization at the 
hyperthermia conditions (Pradhan et al., 2007). Magnetic particles with tuneable Tc will 
prevent the temperature of the whole tumour or the hottest spot around the particle raising 
its temperature over the Curie Temperature, so, avoiding the use of any local temperature 
control system. 
When a ferromagnetic nanoparticle reaches its Curie Temperature it becomes paramagnetic, 
and its magnetic moment drastically decreases. Thus, the eddy currents and the relaxation 
processes decrease as well and the hysteresis losses disappear. This means that the 
nanoparticles will stop heating the medium and the temperature will go back below the 
Curie Temperature becoming ferromagnetic again and so recovering the heating process. 
Therefore, it becomes a self regulating system and the culture temperature will always be 
around the Curie Temperature.  
Bearing in mind all these facts, manganese perovskites meet the requirements for magnetic 
hyperthermia treatments.  
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The manganese oxides perovskite La1-x(SrCa)xMnO3 have a Curie temperature that, 
depending on the cation ratio, can range from 300 K  to 350 K (so 42-44 ºC is within the 
range) and they have large magnetization values of about 30 – 35 emu/g.  
The preparation of the particles is as follows. First the particles are created by the ceramic 
method from compounds of La2O3, CaCO3, SrCO3, and MnO2. These particles obtained by 
the ball milling method form agglomerates due to the dipolar magnetic interaction and the 
lack of surfactants. The agglomerates also have a large size distribution, with sizes greater 
than 1 m. Since the magnetic interaction decreases with temperature, the particles are 
dispersed in ethanol and heated over the Tc in order to disaggregate them and to select the 
smaller ones, thus obtaining an average size of 100 nm. These NPs are not biocompatible so 
they have to be coated with silica following the Stöber method (Stöber et al., 1968).   
The magnetic properties are not significantly affected by the size selection. Since the size is 
around 100 nm, the selected NPs still behave quite like the as-prepared ceramic. However, 
the magnetic properties are affected by the coating: the total magnetization is reduced by the 
presence of diamagnetic silica and the Curie Temperature decreases when the nanoparticles 
are coated. For example, for the composition La0.56(CaSr)0.22MnO3, at low temperature the 
magnetization at 1 kOe decreases from 31 to 21 emu/g (about 32%) while the Tc decreases 
from 68 ºC to 44 ºC for the uncoated and the coated nanoparticles respectively.  
Another problem that must be faced is if it is necessary to increase the temperature up to  
42 – 44 ºC in the whole tumour (so needing magnetic nanoparticles with very high magnetic 
moment or a very high concentration of nanoparticles) (Lacroix et al., 2009) in order to 
induce tumour damage or if it is enough to raise the temperature locally in the cells to 
induce apoptotic tumour death. The study of intracellular hyperthermia can shed light on 
this question. 
Biological tests with perovskites were performed in order to prove their validity as a heating 
source for tumour hyperthermia. They were put inside a culture of HeLa cells. HeLa cells 
are a family of tumour cells widely used by biologists. HeLa cells were incubated with a 
concentration of 0.5 mg/ml of perovskites for 3 h. After incubation, cells were washed 3 
times with PBS and then exposed for 30 min to a 100 KHz alternating magnetic field  
of 15 mT. 
The cells incubated with the perovskites but without being submitted to an alternating 
magnetic field do not show any change, thus, demonstrating that the coating of the 
nanoparticles makes them biocompatible as expected. For the cells submitted to an 
alternating field the cell morphology was not affected immediately after the incubation and 
exposition to AMF. However, the perovskite + AMF treatment provoked deep 
morphological alterations, 24 h after the combined treatment, which corresponds to different 
stages of cell death by an apoptotic process. It is known that apoptosis is a regulated process 
which requires the active participation of specific molecules and is a characteristic 
mechanism of cell death for temperature around 42 ºC. The temperature increase of the 
culture during the application of the AMF (controlled by an infrared thermometer) was 
lower than 0.5 K for the PER incubated HeLa cells. This means that the small size of the 
perovskites cannot heat the cell culture. However, perovskites can induce local hot spots 
that damage irreversibly the structure and functionality of the cell proteins triggering the 
cell apoptosis (Fig 12).  
www.intechopen.com




Fig. 12. Nanoparticles (black spots) inside the cell after apopthosis (White holes) 
(Villanueva, 2010) 
These results show that perovskite nanoparticles have a high potential for cancer cell 
hyperthermia, working as smart mediators for self controlled heating of tumours, where the 
heating source is switched off when the local temperature of the tumour reaches the  
desired value. 
4. Biocompatibility 
In the previous paragraphs it has been shown that the different materials that are used as 
sensors should meet different requirements from the point of view of their magnetic 
properties: the optimal response of the device could be achieved with the softest, the hardest 
or the most magnetostrictive material. It depends on the application. It should be remarked 
that to assure a long-term working life-time of the device, it is necessary to look for a 
material with specific mechanical properties (González-Carrasco, 2009), as for example high 
fatigue resistance for the cardiac valve sensor. In the particular case of the implantable 
devices, it is evident that there is a decisive requirement that is more important than all 
those physical properties. This is, that the device cannot harm the patient, so the system 
must be biocompatible. The definition of the term Biocompatibility says:  “Biocompatibility 
refers to the ability of a material to perform with an appropriate host response in a specific 
situation” (Williams, 1987). 
Bearing in mind, that the human organism can be considered, in a very schematic way, as an 
assemblage of different tissues and fluids with different properties (biological, physical and 
chemical) as well as being a very aggressive medium against exogenous elements, it is easy 
to infer that the problem of the biocompatibility of the materials is very complex and should 
be studied for each specific application (Williams, 2008). In general, biocompatibility studies 
usually begin with in vitro tests (i.e. cell viability, preferably with cells of the host 
tissue/organ, and an endless quantity of trials concerned with the promotion or inhibition 
of biological process) followed by in vivo trials on experimental animals (Ratner et al., 2004). 
Biomaterials, understood as materials that are biocompatible, can be classified in accordance 
with different parameters, for example their nature (metal, ceramic, polymer...), their 
application (bone, vascular, eye...) or their size. For reviewing the state of the 
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biocompatibility of magnetic materials, this last option is more appropriate. Two large 
groups of materials can be distinguished: those used as bulk materials and the 
micro/nanoparticles. 
On the one hand, among the widely established bulk biomaterials (titanium alloys, cobalt-
chromium alloys, noble metals, Nitinol, austenitic stainless steel, alumina, calcium 
phosphates, carbon and polymers like UHMW polyethylene, PMMA or silicones) there are 
none with ferromagnetic properties. Regarding the metallic materials (excepting the noble 
metals, which are not ferromagnetic) only those that develop a well attached surface oxide 
layer usually present a good response to corrosion. In fact, if Chromium is added above 12% 
weight to Fe or Co the alloys become stainless. The stainless steels used for medical 
applications (316L and 304L) also incorporate Ni, among other elements, in their 
composition, which improves their corrosion resistance and stabilizes the face centred cubic 
structure. This latter fact explains their paramagnetic character. 
In general, it could be said that most the ferromagnetic materials are not biocompatible or 
their biocompatibility is not known. Very few papers on the biocompatibility of magnetic 
materials can be found. Even fewer can be found on cells. Most of them are corrosion 
studies done with liquids that simulate the pH of different biological mediums. Magnets 
have attracted interest in medicine (Riley at al., 2002). In particular, rare earth magnets have 
been investigated in the field of dentistry to push or pull teeth or as prostheses retention 
systems (Noar et al., 1999). They show bad corrosion resistance and have been used 
embedded in different polymeric materials or with Ti coating. 
Studies on Fe-Co alloys and magnetostrictive NiMnGa and Terfenol_D show poor cell 
viability, excepting the last one that presents high corrosion (Pouponneau et al. 2006). 
However the system Co-Pt and Fe-Pt show better corrosion response (Yiu et al. 2004)). At 
research level, the Fe based alloy PM2000 shows good corrosion behaviour and cell viability 
together with a significant saturation magnetization, especially when coated with alumina 
by thermal oxidation (Flores et al., 2004). 
The surface is where the first contact between the material and the biological entity takes 
place. This is why surface biomaterials are being researched in depth, while surface 
modification is one of the most widely used strategies for improving biomaterial properties.  
In the case where a magnetic feature can only be achieved with a material that is not 
biocompatible the simplest solution is to encapsulate it or to coat it with a biocompatible 
material. Anyway, as coatings also present their own problems (adherence, thickness,...), it 
would be very interesting to investigate and to develop biomaterials with good  
magnetic properties. 
On the other hand, there already exist some nanoparticles commercially used as contrast 
agents in imaging diagnostic techniques or drug targeting and magnetic separation 
applications, like the Iron Oxide or the Gd, because of their magnetic properties. However, 
an enormous effort is being made to develop biocompatible magnetic nanoparticles for their 
application in biomedicine due to the attractive possibilities that they offer (Pankhurst, 2003) 
as hyperthermia agents for coadyuvant cancer treatment, drug delivery systems, as well as 
for the previously mentioned reasons.  
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The problem of the toxicity of nanoparticles goes further than in vitro trials with cells, (it can 
be really complex) (Lewinsky, 2008). In fact this kind of material has other problems when 
used for long term devices. For example, once their behaviour with cells has been tested, it is 
essential to understand their survival in the body. Do the macrophages detect them too soon 
or on the contrary, do the nanoparticles tend to accumulate in some important organ such as 
the liver or brain? (Hoet et al., 2004). Nanoparticles are frequently coated with different 
organic or inorganic materials (as dextran (Lacava, 2001) or silica (Villanueva, 2010)). 
Sometimes this is done to make them biocompatible, sometimes to obtain an appropriate 
dispersion and sometimes to functionalize them. 
5. Further research 
Magnetic sensors can be applied in several fields of Biology and Medicine. Practically all the 
devices mentioned in this chapter are still in the optimization phase or in clinical trials. So, 
the related research is still ongoing.  
The hyperthermia treatment studies for malignant tumors merit, because of their enormous 
interest, to be discussed separately. This is research with a marked interdisciplinary character, 
since it presents challenges that specifically concern doctors, biologist, chemists, material´s 
engineers and, of course, physicists. Although nowadays, nanoparticles have been achieved 
that seem to work very well, there remain problems that are far from being solved. 
 To determine if the origin of the damage produced to the tumor cells comes from the 
temperature increase or from the movement of the particles inside the cells themselves. 
 To concentrate the particles in the nearby tumor area and avoiding most of them being 
eliminated by the reticulum-endothelial along the path to the tumor. 
 To control the temperature treatment inside a medium that the circulatory system keeps 
constantly at 37oC. 
 To eliminate the particles from the patient´s body after the treatment and avoiding their 
concentration in organs, such as the kidneys, liver, spleen, etc. 
 To concentrate the high frequency magnetic field in the tumor area, in order to avoid 
heating the particles that have been absorbed by other organs or tissues. 
 Last but not least, to manufacture cheap nanoparticles so that if the treatment works, 
everybody can have access to it.  
Another area of research we are interested in is the application of magnetic sensors and 
actuators in remote monitoring of multiple sclerosis patients. Multiple sclerosis (MS) is a 
chronic, degenerative disease that affects young people and which , according to the last 
survival studies, not only shortens life approximately by 10 years but also produces 
important limitations and deficiencies affecting the wellbeing of the patient, over the course 
of its development.  
During its progress, MS patients present a very varied symptomatology. So, in the first 
stages of the disease it is usually asymthomatic and without objective neurological 
deficiencies. It is only during the 5 first years that objective neurological manifestations 
begin to appear. As a general rule, after between 10 to 15 years of development, the 
deficiencies are very evident and begin to have clear repercussions on the physical and 
cognitive activities of the patients. Between the 15th and 20th years of development, the 
www.intechopen.com
 Magnetic Sensors for Biomedical Applications 
 
147 
limitations increase by up to 33%, which means severe restrictions on mobility. In these 
advanced stages of the disease, the symptoms limit the patient’s mobility very severely and 
drastically affect the quality of life and autonomy of these patients.   
The goal of this research would be to exploit the possibilities offered by telemedicine and  
remote control for improving the assistance, monitoring and quality of life in MS patients, in 
the advanced stages and with very  limited mobility.   
It would be focused on three aspects: 




 Autonomic alteration: cardiac rhythm, blood-pressure variations, gastrointestinal 
mobility alterations and sphincters control (anal and urethral)  
 Position 
 Sleep quality  
 Development of complications derived from the physical condition  
 Decubitus ulcers 
 Urine infection 
 Respiratory infection (aspiration) 
 Position alteration (orthopaedic malformation) 
 Clinical  evolution monitoring ( search of image subrogated markers obtained by 
periodical and quantifiable Magnetic Resonance studies)  
 Walk monitoring 
 Upper limbs monitoring 
 Mental function monitoring 
 Autonomic state monitoring 
These neurological requirements scenarios could be analyzed  at a distance by using the 
appropriate sensors (with calls and alerts), so that the neurologist would be able to treat the 
patient without the patient needing to be in presence of the physician and so avoiding 
complications that would decrease the quality of life. 
6. Conclusion 
It is not possible in the space available to offer an exhaustive overview of the applications of 
magnetic sensors in the field of medicine. We have limited ourselves to presenting just some 
particular works, that we have recently developed, some that are currently being developed 
and some that are still in the future. 
It seems obvious that the development of magnetic sensors and actuators is generally linked 
to the development of magnetic materials. Furthermore, it could be said that the 
development of our technological civilization is linked to the development of magnetic 
materials. If this assertion sounds too exaggerated, please imagine the consequences of the 
disappearance of the silicon steel sheet and with it all the electric motors and transformers. 
Or just think about the permanent magnets inside all mobile phones, or the magnetic 
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information storage medium. Or, going back in time, at what stage of development would 
we be without the great discoveries made possible by the compass. 
This is even more evident in the case of the biomedical applications. The increasingly strict 
requirements for sensors and actuators in the field of safety, as well as for biocompatibility, 
corrosion, miniaturization, low consumption, etc. are impossible to meet without new 
magnetic materials. Just think that the fight against the most feared disease of our time 
could depend on something so simple (but not easy) as the suitable magnetic material. 
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